Thompson, P. A., & Wierda, W. G. (2016). Eliminating minimal residual disease as a therapeutic end point: Working toward cure for patients with CLL. Blood.
Čikaški stil citiranjaThompson, Philip A., i William G. Wierda. "Eliminating Minimal Residual Disease As a Therapeutic End Point: Working Toward Cure for Patients With CLL." Blood 2016.
MLA način citiranjaThompson, Philip A., i William G. Wierda. "Eliminating Minimal Residual Disease As a Therapeutic End Point: Working Toward Cure for Patients With CLL." Blood 2016.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.